Patent · US Active

Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase

US10301376B2 · kind B2 · utility

12Cited by

55References

47Claims

0Family size

Assignee

Baxalta Incorporated · CH

Inventors

Richard Schiff · Santa Rosa, US
Heinz Leibl · Perchtoldsdorf, AT

Key dates

Filing date	Mar 16, 2009
Grant date	May 28, 2019
Priority date	—
Expiry date	Mar 16, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are combinations, compositions and kits containing a immune globulin (IG) composition and a soluble hyaluronidase composition formulated for subcutaneous administration. Such products can be used in methods of treating IG-treatable diseases or conditions. Also provided are methods for subcutaneous administration of immune globulin whereby the dosing regimen is substantially the same as for intravenous administration of the same dosage for treatment of the same IG-treatable disease or condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.